Log In
Print
BCIQ
Print
Print this Print this
 

CT-1578

  Manage Alerts
Collapse Summary General Information
Company CTI BioPharma Corp.
DescriptionJanus kinase-2 (JAK-2) inhibitor and has activity against FMS-like tyrosine kinase 3 (FLT3; CD135) and colony-stimulating factor 1 receptor (CSF1R; C-FMS; CD115)
Molecular Target Janus kinase-2 (JAK-2)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationRheumatoid arthritis (RA)
Indication DetailsTreat rheumatoid arthritis (RA)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today